Cargando…

Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease

BACKGROUND: The eosinophilic chronic obstructive pulmonary disease (COPD) is known to be more sensitive to corticosteroid. The sputum microbiome has been shown to affect COPD prognosis, but its role in acute exacerbations of eosinophilic COPD is unclear. This study aimed to investigate the dynamic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yu-Jing, Sun, Xue-Jiao, Wang, Zhe, Bin, Yan-Fei, Li, Ying-Hua, Zhong, Xiao-Ning, Bai, Jing, Deng, Jing-Min, He, Zhi-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065869/ https://www.ncbi.nlm.nih.gov/pubmed/32053571 http://dx.doi.org/10.1097/CM9.0000000000000677

Ejemplares similares

Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease
por: Liu, Hai-Yue, et al.
Publicado: (2017)

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease
por: Manjhi, Rekha, et al.
Publicado: (2022)

Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state
por: Yang, Chia-Yu, et al.
Publicado: (2021)

Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability
por: Dang, Xiaomin, et al.
Publicado: (2022)

Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices
por: Su, Linfan, et al.
Publicado: (2022)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Sputum Inflammometry to Manage Chronic Obstructive Pulmonary Disease Exacerbations: Beyond Guidelines
por: Venegas, Carmen, et al.
Publicado: (2020)

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Su, Linfan, et al.
Publicado: (2022)

Eotaxin and IL-4 levels are increased in induced sputum and correlate with sputum eosinophils in patients with nonasthmatic eosinophilic bronchitis
por: Zhang, Rui, et al.
Publicado: (2017)

Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
por: Ma, Nan, et al.
Publicado: (2021)

Sputum Inflammatory Cell-Based Classification of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Gao, Peng, et al.
Publicado: (2013)

Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
por: Jang, A. S., et al.
Publicado: (2000)

Eosinophile Cells in the Sputum in Asthma
Publicado: (1910)

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV(1) and eosinophilic exacerbations
por: Aziz-Ur-Rehman, Afia, et al.
Publicado: (2017)

Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2015)

The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD)
por: Lv, Mei-Yu, et al.
Publicado: (2021)

Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease
por: Liu, Dong, et al.
Publicado: (2015)

Similar activation of sputum granulocytes in eosinophilic and non-eosinophilic asthma
por: Hilvering, Bart, et al.
Publicado: (2015)

Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Liu, Tao, et al.
Publicado: (2021)

Could the Sputum Microbiota Be a Biomarker That Predicts Mortality after Acute Exacerbations of Chronic Obstructive Pulmonary Disease?
por: Tsay, Jun-Chieh J., et al.
Publicado: (2019)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
por: Tang, Bin, et al.
Publicado: (2020)

Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease
por: Wang, Yating, et al.
Publicado: (2023)

Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus‐predominant subgroup
por: Diver, Sarah, et al.
Publicado: (2019)

Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Hegewald, Matthew J, et al.
Publicado: (2020)

Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Wu, Hong-Xia, et al.
Publicado: (2019)

Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study
por: Mohan, Sindu, et al.
Publicado: (2017)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Eosinophil Activation Markers in Induced Sputum in Asthmatics
por: Jang, An-Soo, et al.
Publicado: (2000)

Association between blood eosinophil count and bacterial infection and clinical outcomes in patients with severe exacerbations of chronic obstructive pulmonary disease
por: Wang, Fei, et al.
Publicado: (2022)

Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection
por: Kayongo, Alex, et al.
Publicado: (2023)

Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Tan, Caimei, et al.
Publicado: (2016)

Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
por: Fachri, Muhammad, et al.
Publicado: (2023)

The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
por: Choi, Juwhan, et al.
Publicado: (2019)

Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis
por: Chan, Ming Chiu, et al.
Publicado: (2020)

Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease
por: Kwok, Wang Chun, et al.
Publicado: (2023)

Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease
por: Diao, Wenqi, et al.
Publicado: (2018)

Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study
por: Dai, Guangming, et al.
Publicado: (2020)

Eosinophilic Chronic Obstructive Pulmonary Disease
por: Weissler, Jonathan C., et al.
Publicado: (2021)

Blood Eosinophil Endotypes across Asthma and Chronic Obstructive Pulmonary Disease (COPD)
por: Luo, Jia-Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ve1ql8p7tvgvuaienq4784cbmp